ACTINOBAC BIOMED, INC.

Basic Information

675 US Highway 1
North Brunswick, NJ, 08902-3378

Company Profile

n/a

Additional Details

Field Value
DUNS: 829616676
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Targeting B-cell lymphoma with Leukothera-phase II

    Amount: $1,500,000.00

    DESCRIPTION (provided by applicant): B-cell lymphoma is cancer of B-lymphocytes and accounts for more than 20,000 deaths in the U.S. each year. While many patients respond to currently available thera ...

    STTR Phase II 2014 Department of Health and Human Services
  2. Targeting B-cell lymphoma with Leukothera

    Amount: $202,601.00

    DESCRIPTION (provided by applicant): B-cell lymphomas include Hodgkin's, and non-Hodgkin's lymphoma (NHL) (eg. mantle cell lymphoma (MCL), follicular lymphoma (FL), diffuse large B-cell lymp ...

    STTR Phase I 2012 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government